Location History:
- Mainz, DE (2020)
- Kerzenheim, DE (2023)
Company Filing History:
2 out of 23 
1 out of 2 
1 out of 7 Years Active: 2020-2023
Title: Lisa Hebich: Innovator in Immunotherapy
Introduction
Lisa Hebich is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of immunotherapy, particularly through her innovative patents. With a total of 2 patents, her work focuses on advancing medical treatments that harness the immune system.
Latest Patents
Hebich's latest patents include "Claudin-18.2-specific immunoreceptors and T cell epitopes" and "Method and kit for determining whether a subject shows an immune response." The first patent provides Claudin-18.2-specific immunoreceptors, including T cell receptors and artificial T cell receptors (chimeric antigen receptors; CARs), which are useful for immunotherapy. The second patent relates to a kit and a method for determining whether a subject shows an immune response against an antigen.
Career Highlights
Throughout her career, Lisa Hebich has worked with notable companies such as BioNTech Diagnostics GmbH and Tron—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg—Universität Mainz Gemeinnützige GmbH. Her work in these organizations has allowed her to contribute to groundbreaking research and development in the field of immunotherapy.
Collaborations
Hebich has collaborated with esteemed colleagues, including Ugur Sahin and Tana Omokoko. These partnerships have further enhanced her research and innovation in the medical field.
Conclusion
Lisa Hebich is a trailblazer in the realm of immunotherapy, with her patents paving the way for new treatment methodologies. Her contributions to the field are invaluable and continue to inspire advancements in medical science.